<DOC>
	<DOCNO>NCT02132221</DOCNO>
	<brief_summary>This research do well understand help patient receive enough relief opioid prescription medication chronic non-cancer pain . Opioids group medication include morphine , oxycodone- , hydrocodone- , etc . These medication also call narcotic . Research show patient benefit opioid prescription medication often feel well stop taking . However , stop reduce pain medication difficult transition . Although much benefit medication , many patient afraid stop feel medication thing give bit relief . Different strategy use help patient period taper clear one best . The investigator test specific approach use regular care clinic : cognitive therapy .</brief_summary>
	<brief_title>Cessation Long-term Opioid Therapy Chronic Pain Patients</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<criteria>Male Female , age 18 . Chronic noncancer pain ( pain 6 month , current pain attribute cancerous disease ) . Referrals Massachusetts General Hospital ( MGH ) Center Pain Medicine opioid taper . Chronic ( 3 month ) prescription morphine , oxycodone , hydrocodone , hydromorphone , codeine formulation medication . Morphine dose equivalent 60 mg . Opioid treatment stable ( plus minus20 % ) last 3 month . Meeting Substance Abuse Mental Health Services Administration ( SAMHSA ) criteria exit chronic opioid therapy Willingness taper participate treatment randomize ( include cognitive workshop session ) , able meet protocol followup schedule activity Agreement undergo random urine toxicology assay , recommend prescribe physician study . Agreement sign opioid contract , recommend prescribing physician . Informed consent study ( IRB approve informed Consent form ) . English Language Literacy . Methadone , suboxone fentanyl patch : tapering opioids would comparable patient . As enrolment open 12 month , patient motivate participate study , could refer pain clinic advice switch medication could allow inclusion . They would , 3 month switch , become eligible study . Pregnancy . History epilepsy druginduced seizure . Proof current diversion drug recent substance related legal problem ( e.g . buying/selling street ) . Concurrent use illicit drug narcotic ( urine toxicology ) , active diagnosis substance abuse dependence disorder within last 3 month . Absence prescribe drug urine toxicology Refusal taper dose reduction trial . Preference suboxone related treatment . Severe psychiatric condition and/or cognitive deficit limit patient 's ability participate Involved concurrent opioid management acute pain condition . Current suicidal ideation . Severe unstable medical illness include cardiovascular , hepatic , renal , respiratory , endocrine , neurological hematological disease . General condition would impede participation group intervention , assess evaluate physician ( e.g . cognitive impairment , tendency towards physical aggression ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Chronic non cancer pain</keyword>
	<keyword>Long term opioid therapy</keyword>
	<keyword>Side effect</keyword>
	<keyword>risk</keyword>
	<keyword>function</keyword>
	<keyword>negative benefit/risk ratio</keyword>
</DOC>